Two important regulatory developments are converging in the United States and the United Kingdom at the same time for the ill-fated COVID-19 investigational vaccines. In America, the Centers for Disease Control has logged more grim milestones as of June 4, 2021, with...
Protect the Most Defenseless from Government Agency Malfeasance
Never in modern American medicine have we witnessed the unbridled recommendation by government agencies encouraging pregnant women to volunteer for a brand-new experimental, untested biological product.
The SARS-CoV-2 viral outbreak and COVID-19 pandemic have driven global fear and panic, which is the sociological set-up for accepting mass vaccination. The USFDA and the vaccine manufacturers excluded pregnant women and those of childbearing potential, which could not guarantee contraception from the registrational trials of the vaccine. This was done to protect the safety of the mother and the baby from the unknown effects of the investigational vaccine.
Regulatory practice always calls for the exclusion of groups not studied from receiving new products when they are released to the public. In a gigantic break from this safe and reasonable practice, with no proof of benefit or evidence of safety, the CDC committed malfeasance by recommending that pregnant women volunteer for the vaccine.
It is known that COVID-19 is in general mild and self-limiting in pregnant women, does not cause fetal malformations, and when presenting with severe symptoms, can be treated with drug therapy including hydroxychloroquine, antibiotics, steroids, and aspirin. The only vaccines allowed in pregnant women are biologically inactive: influenza, tetanus, diphtheria, and pertussis.
So why would the CDC take such a reckless approach with pregnant women with absolutely no assurances to mothers that the pregnancy would be safe after vaccination?
Given the great despair over the nation, the CDC may have wanted to make a broad offering to the public without restrictions. Since the CDC does not make accountable treatment recommendations or directly care for patients, it may have felt justified in this approach. Thus, it is up to each woman to do her own research on this very important decision in pregnancy or childbearing years.
It is understood that all vaccines cause the body to make an uncontrolled amount of the dangerous viral spike protein that circulates in the body and causes fever, chills, nausea, vomiting, low blood pressure, none of which are good for pregnant women.
Even worse, the spike protein causes damage to blood vessels and promotes blood clotting. The placenta is the most vulnerable organ to the marauding effects of the vaccine-induced S-protein, and the consequences are being seen as women elect to undergo investigational vaccination.
The McCullough Report: Sat/Sun 2 PM ET Encore 7 PM – Internationally recognized Dr. Peter A. McCullough, known for his iconic views on the state of medical truth in America and around the globe pierces through the thin veil of mainstream media stories that skirt the major issues and provide no tractable basis for durable insight.
As of May 7, 2021, 275 miscarriages have been reported to the CDC in women who were needlessly vaccinated. Given the strict nature of reporting, including penalties for false reports, it is estimated that only 1-10% of safety reports are logged by the CDC after vaccination. Thus, at this time, American women have probably lost >2000 babies to the COVID-19, and that number will continue to rise until either the vaccines are pulled from the market or pregnant women are excluded.
This week’s broadcast has expert opinions from multiple leading physicians across North America giving caution about indiscriminate vaccination, and none of them recommend the vaccine for pregnant women. There is no more urgent message from The McCullough Report, under no circumstances should a pregnant woman comply with reckless CDC recommendations—please decline elective, investigational vaccination.
McCullough PA, Alexander PE, Armstrong R, Arvinte C, Bain AF, Bartlett RP, Berkowitz RL, Berry AC, Borody TJ, Brewer JH, Brufsky AM, Clarke T, Derwand R, Eck A, Eck J, Eisner RA, Fareed GC, Farella A, Fonseca SNS, Geyer CE Jr, Gonnering RS, Graves KE, Gross KBV, Hazan S, Held KS, Hight HT, Immanuel S, Jacobs MM, Ladapo JA, Lee LH, Littell J, Lozano I, Mangat HS, Marble B, McKinnon JE, Merritt LD, Orient JM, Oskoui R, Pompan DC, Procter BC, Prodromos C, Rajter JC, Rajter JJ, Ram CVS, Rios SS, Risch HA, Robb MJA, Rutherford M, Scholz M, Singleton MM, Tumlin JA, Tyson BM, Urso RG, Victory K, Vliet EL, Wax CM, Wolkoff AG, Wooll V, Zelenko V. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med. 2020 Dec 30;21(4):517-530. DOI: 10.31083/j.rcm.2020.04.264. PMID: 33387997.
Use the code ‘OUTLOUD’ and receive your 20% discount on your first order.